Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 5 EP applications Nico Riffel has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13722415

METHODS FOR THE ACTIVATION OF SILENT GENES IN A MICROORGANISM

IPC classification:
C12N 1/14, C12N 1/20, C12N 1/38, C12P 1/00, C12Q 1/02, C12R 1/01, C12R 1/645
Applicant:
Sanofi, S.A.
Agent:
Nico Riffel, Sanofi-Aventis Deutschland GmbH
Status:
EXAMINATION IN PROGRESS
EP13722414

METHOD FOR PRODUCING RECOMBINANT 11-DE-O-METHYLTOMAYMYCIN

IPC classification:
A61K 31/445, C07D 519/00
Applicant:
Sanofi, S.A.
Agent:
Nico Riffel, Sanofi-Aventis Deutschland GmbH
Status:
GRANT OF PATENT INTENDED
EP14306740

21-Hydroxylation of steroids

IPC classification:
C12P 33/06
Applicant:
Sanofi, S.A.
Agent:
Nico Riffel, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP15306106

FUSION MOLECULES

IPC classification:
C07K 14/47
Applicant:
Sanofi, S.A.
Agent:
Nico Riffel, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION REFUSED
EP15787993

21-HYDROXYLATION OF STEROIDS

IPC classification:
C12P 33/06
Applicant:
Sanofi, S.A.
Agent:
Jörk Zwicker, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Nico Riffel, Sanofi-Aventis Deutschland GmbH
Status:
Request for examination was made

Please Sign in to use this feature